RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature
Pathology International · 2026-07 · 76 (7)
DOI: 10.1111/pin.70150 ↗Kurz gefasst
Fallbericht in der Zeitschrift Pathology International, online erschienen am 21.07.2026. Verfasst von Furkan Aknar und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul Medeniyet University, Istanbul, Türkiye. Hauptthemen laut MEDLINE: Glioma, Retinoblastoma Binding Proteins, Ubiquitin-Protein Ligases, Spinal Neoplasms. Die Arbeit nennt 15 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
High‐grade glioma with pleomorphic and pseudopapillary features (HPAP) is a recently described entity defined by a distinct DNA methylation signature, recurrent monosomy 13, and mutations in TP53, RB1, and NF1. Most cases are supratentorial with a relatively favorable prognosis. We report a 45‐year‐old woman who presented with a right cerebellar mass exhibiting striking histopathological heterogeneity comprising low‐grade and high‐grade components. The high‐grade component demonstrated a p53 null immunophenotype and complete loss of RB1 expression, contrasting with wild‐type staining in the low‐grade areas. Molecular analysis confirmed pathogenic variants in TP53 (p.Pro27LeufsTer17), NF1, and NF2, with losses of chromosomes 13 and 17. Despite gross total resection and adjuvant chemoradiotherapy, the patient developed spinal intradural metastasis 26 months postoperatively. The metastatic lesion mirrored the high‐grade primary component immunohistochemically and harbored a newly acquired TERT promoter mutation. DNA methylation profiling of the spinal metastasis classified the tumor as HPAP. This case represents the first documented spinal metastasis and the first p53 null phenotype in HPAP, suggesting a potential role for combined RB1 and p53 immunohistochemistry in the diagnostic workup and highlighting the capacity for neuraxis dissemination in this emerging entity.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pathology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Pathology, National Institutes of Health, National Cancer Institute, Bethesda, Maryland, USA.
- Department of Radiology, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul Medeniyet University, Istanbul, Türkiye.
- Department of Neurosurgery, Göztepe Prof. Dr. Süleyman Yalçın City Hospital, Istanbul Medeniyet University, Istanbul, Türkiye.
ORCID-Profile: Furkan Aknar, Tuce Soylemez-Akkurt, Pinar Engin Zerk, Basak Atalay, Mehmet Sabri Gürbüz, Numan Karaarslan
Zitieren
APA
Aknar, F., Soylemez-Akkurt, T., Engin Zerk, P., Atalay, B., Gürbüz, M. S., & Karaarslan, N. (2026). RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature. Pathology International, 76(7). https://doi.org/10.1111/pin.70150
Vancouver
Aknar F, Soylemez-Akkurt T, Engin Zerk P, Atalay B, Gürbüz MS, Karaarslan N. RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature. Pathology International. 2026;76(7). doi:10.1111/pin.70150
BibTeX
@article{Aknar2026,
author = {Aknar, Furkan and Soylemez-Akkurt, Tuce and Engin Zerk, Pinar and Atalay, Basak and Gürbüz, Mehmet Sabri and Karaarslan, Numan},
title = {RB1 Loss as a Diagnostic Clue in a High‐Grade Glioma With Pleomorphic and Pseudopapillary Features (HPAP): The First Reported Case With Spinal Metastasis and a Review of the Literature},
journal = {Pathology International},
year = {2026},
volume = {76},
number = {7},
doi = {10.1111/pin.70150}
}
EUVIMED